首页|埃克替尼对肺动脉高压大鼠右心室重构的保护作用

埃克替尼对肺动脉高压大鼠右心室重构的保护作用

扫码查看
目的 研究埃克替尼对野百合碱(MCT)诱导的肺动脉高压(PH)大鼠右心室重构的影响.方法 将SD大鼠随机分为对照组(0.3%羧甲基纤维素钠)、模型组和低、高剂量实验组(30、60 mg·kg-1埃克替尼),每组8只.模型组和低、高剂量实验组单次腹腔注射60 mg·kg-1 MCT建立大鼠肺动脉高压模型.MCT注射后连续给药4周.检测各组大鼠血流动力学指标,以原位末端标记法(TUNEL)染色检测右心室细胞凋亡情况,以蛋白质印迹法检测右心室B细胞淋巴瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)、活化的胱天蛋白酶-3(cleaved-caspase-3)、表皮生长因子受体(EGFR)、磷酸化EGFR(p-EGFR)、视神经萎缩症蛋白1(Opa1)和线粒体融合蛋白2(Mfn2)的蛋白表达情况.结果 低、高剂量实验组和对照组、模型组右心室收缩压分别为(38.58±4.98)、(34.15±3.88)、(23.66±2.45)和(45.07±5.78)mmHg;平均肺动脉压分别为(27.85±3.77)、(24.25±3.09)、(17.33±2.46)和(33.07±4.15)mmHg;右心室/(左心室+室间隔)分别为(36.38±5.51)%、(33.63±4.69)%、(22.25±2.96)%和(42.50±7.33)%;右心室/胫骨长度分别为(69.33±7.86)、(62.69±7.17)、(49.12±6.42)和(78.22±9.07)mg·cm-1.低、高剂量实验组的上述指标与模型组比较,在统计学上差异均有统计学意义(均P<0.01).低、高剂量实验组 Bel-2、Bax、cleaved caspase-3、p-EGFR、Opa1、Mfn2与模型组相比,在统计学上差异均有统计学意义(P<0.05,P<0.01).结论 埃克替尼能够抑制MCT诱导的PH大鼠右心室重构,其机制可能与其降低右心室p-EGFR水平、缓解线粒体功能紊乱、抑制心肌细胞凋亡有关.
Protective effect of icotinib on right ventricular remodeling in pulmonary hypertension rats
Objective To investigate the effect of icotinib on right ventricular remodeling in rats with monocrotaline(MCT)-induced pulmonary hypertension(PH).Methods Sprague-Dawley rats were randomly divided into control group(0.3%sodium carboxymethyl cellulose),model group and low,high dose experimental groups(30,60 mg·kg-1 icotinib),8 rats in each group.PH rat model was established by single intraperitoneal injection of 60 mg·kg-1 MCT in model group and low,high dose experimental groups.The drug was administered continuously for 4 weeks after MCT injection.The hemodynamic indexes of each group were detected.Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling(TUNEL)staining was used to detect the apoptosis of right ventricular cardiomyocytes.The protein levels of B cell lymphoma-2(Bcl-2),Bcl-2 associated X protein(Bax),cleaved cysteine aspartic acid specific protease-3(cleaved-caspase-3),epidermal growth factor receptor(EGFR),phosphorylated EGFR(p-EGFR),optic atrophy 1(Opa1)and mitofusin 2(Mfn2)were detected by Western blot analysis.Results The right ventricular systolic pressure in low,high dose experimental groups and control group,model group were(38.58±4.98),(34.15±3.88),(23.66±2.45)and(45.07±5.78)mmHg;the mean pulmonary artery pressure were(27.85±3.77),(24.25±3.09),(17.33±2.46)and(33.07±4.15)mmHg;the right ventricle(RV)to left ventricle+septum were(36.38±5.51)%,(33.63±4.69)%,(22.25±2.96)%and(42.50±7.33)%;the RV to tibial length were(69.33±7.86),(62.69±7.17),(49.12±6.42)and(78.22±9.07)mg·cm-1.There were significant differences in the above indexes between low,high dose experimental groups and model group(all P<0.01).There were significant differences in Bcl-2,Bax,cleaved caspase-3,p-EGFR,Opa1,Mfn2 between low,high dose experimental groups and model group(P<0.05,P<0.01).Conclusion Icotinib can inhibit right ventricular remodeling in PH rats induced by MCT,and its mechanism may be related to reducing the phosphorylation level of EGFR in the right ventricle,alleviating mitochondrial dysfunction and inhibiting cardiomyocyte apoptosis.

icotinibright ventricular remodelingepidermal growth factor receptormitochondrial dysfunction

胡霞、顾文强、严静静、黄维琳、李先伟

展开 >

安徽中医药高等专科学校基础教学部,安徽芜湖 241000

皖南医学院药学院药理学教研室,安徽芜湖 241002

埃克替尼 右心室重构 表皮生长因子受体 线粒体功能障碍

安徽省高等学校自然科学研究重大项目安徽省高等学校自然科学研究重点项目

KJ2021ZD01062023AH053200

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(12)
  • 14